SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
<em></em><em>This article presents the safety data for cell-derived inactivated subunit adjuvanted influenza vaccine «Grippol Neo» in children 3–17 years old in comparison with reference egg-derived inactivated subunit vaccine «Grippol plus». Good test vaccine tolerability and high...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2010-01-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/919 |
| _version_ | 1797701609477636096 |
|---|---|
| author | S.M. Kharit M.K. Erofeeva N.Yu. Nikanorov V.V. Romanenko S.V. Komleva |
| author_facet | S.M. Kharit M.K. Erofeeva N.Yu. Nikanorov V.V. Romanenko S.V. Komleva |
| author_sort | S.M. Kharit |
| collection | DOAJ |
| description | <em></em><em>This article presents the safety data for cell-derived inactivated subunit adjuvanted influenza vaccine «Grippol Neo» in children 3–17 years old in comparison with reference egg-derived inactivated subunit vaccine «Grippol plus». Good test vaccine tolerability and high efficacy profile is demonstrated. Based on the results obtained vaccine «Grippol Neo» is recommended for mass influenza prophylaxis in pediatry, including National Immunization Schedule.</em><span style="text-decoration: underline;"><em><br /></em></span><em><strong>Key words: children, influenza, vaccination, «Grippol Neo».</strong></em><span style="text-decoration: underline;"><em><br />(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):44-49)</em></span> |
| first_indexed | 2024-03-12T04:39:14Z |
| format | Article |
| id | doaj.art-958eedd954d94c1dbac42a4f2851abd0 |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2024-03-12T04:39:14Z |
| publishDate | 2010-01-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-958eedd954d94c1dbac42a4f2851abd02023-09-03T09:50:00Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-01-01944449920SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIALS.M. Kharit0M.K. Erofeeva1N.Yu. Nikanorov2V.V. Romanenko3S.V. Komleva4Scientific Institute of Children’s Infections, St.-PetersburgScientific Institute of Influenza, North-West Department of Russian Academy of Medical Sciences, St.-PetersburgScientific Institute of Influenza, North-West Department of Russian Academy of Medical Sciences, St.-PetersburgCenter of Hygiene and Epidemiology in Sverdlovsk Region, YekaterinburgChildren’s Clinical Hospital № 8, Yekaterinburg<em></em><em>This article presents the safety data for cell-derived inactivated subunit adjuvanted influenza vaccine «Grippol Neo» in children 3–17 years old in comparison with reference egg-derived inactivated subunit vaccine «Grippol plus». Good test vaccine tolerability and high efficacy profile is demonstrated. Based on the results obtained vaccine «Grippol Neo» is recommended for mass influenza prophylaxis in pediatry, including National Immunization Schedule.</em><span style="text-decoration: underline;"><em><br /></em></span><em><strong>Key words: children, influenza, vaccination, «Grippol Neo».</strong></em><span style="text-decoration: underline;"><em><br />(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):44-49)</em></span>http://vsp.spr-journal.ru:80/jour/article/view/919 |
| spellingShingle | S.M. Kharit M.K. Erofeeva N.Yu. Nikanorov V.V. Romanenko S.V. Komleva SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL Вопросы современной педиатрии |
| title | SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL |
| title_full | SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL |
| title_fullStr | SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL |
| title_full_unstemmed | SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL |
| title_short | SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL |
| title_sort | safety of cell derived subunit adjuvanted influenza vaccine for children vaccination double blind randomized clinical trial |
| url | http://vsp.spr-journal.ru:80/jour/article/view/919 |
| work_keys_str_mv | AT smkharit safetyofcellderivedsubunitadjuvantedinfluenzavaccineforchildrenvaccinationdoubleblindrandomizedclinicaltrial AT mkerofeeva safetyofcellderivedsubunitadjuvantedinfluenzavaccineforchildrenvaccinationdoubleblindrandomizedclinicaltrial AT nyunikanorov safetyofcellderivedsubunitadjuvantedinfluenzavaccineforchildrenvaccinationdoubleblindrandomizedclinicaltrial AT vvromanenko safetyofcellderivedsubunitadjuvantedinfluenzavaccineforchildrenvaccinationdoubleblindrandomizedclinicaltrial AT svkomleva safetyofcellderivedsubunitadjuvantedinfluenzavaccineforchildrenvaccinationdoubleblindrandomizedclinicaltrial |